Drugs / 15-Valent Pneumococcal Conjugate Vaccine
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04108845 | Jun 2019 → Aug 2020 | streptococcal pneumonia | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT06817187 | Sep 2021 → Mar 2024 | pneumococcal infection | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 3 | NCT04357522 | Jul 2020 → Mar 2026 | streptococcal pneumonia | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05939219 | Jul 2023 → Jan 2025 | — | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06524414 Comparator | Jul 2024 → May 2027 expected | pneumococcal infection | Pfizer | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 15-valent pneumococcal conjugate vaccine | “15-valent pneumococcal conjugate vaccine” NCT06817187 ↗ |
| Modality | Vaccine | “15-Valent Pneumococcal Conjugate Vaccine” NCT04108845 ↗ |
| Route | Intramuscular | “Single intramuscular dose” NCT04108845 ↗ |